Preosteoblast-enriched lnc-Evf2 facilitates osteogenic differentiation by targeting Notch

Acta Biochim Biophys Sin (Shanghai). 2021 Feb 4;53(2):179-188. doi: 10.1093/abbs/gmaa156.

Abstract

Ossification of ligaments (OL) and osteoporosis (OP) are multifactorial disorders without definitive clinical biomarkers. Long non-coding RNAs (lncRNAs) are known to involve in regulating pathogenesis. Here, we have identified a preosteoblast-enriched lnc-Evf2 that was overexpressed in ossified ligamentum flavum (OLF) and down-expressed in OP. lnc-Evf2 is gradually upregulated during osteogenic induction, correlating with the enhanced expression of osteogenic marker genes and matrix mineralization. Moreover, knockdown of lnc-Evf2 significantly inhibits the expression of osteogenic differentiation markers and delays the osteoblastic mineralization process, indicating that this molecule is involved in osteogenesis. Mechanistically, we demonstrated that silencing of lnc-Evf2 decreases the protein level but not the mRNA levels of Notch2, Notch3, and Hes1, all of which correlate with osteogenesis. Taken together, our data demonstrate that lnc-Evf2 promotes osteogenic differentiation and bone formation through the Notch signaling, revealing that lnc-Evf2 may serve as a novel potential clinical target of OL and OP.

Keywords: Notch; lncRNA; ossification of ligaments; osteogenic differentiation; osteoporosis.

MeSH terms

  • Animals
  • Cell Differentiation*
  • Cell Line
  • Mice
  • Osteoblasts / metabolism*
  • Osteogenesis*
  • RNA, Long Noncoding / genetics
  • RNA, Long Noncoding / metabolism*
  • Receptors, Notch / genetics
  • Receptors, Notch / metabolism*

Substances

  • RNA, Long Noncoding
  • Receptors, Notch